Related Experiment Video
Updated: Aug 11, 2026

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
Published on: May 6, 2018
Minimal change nephrotic syndrome in children with intrauterine growth retardation
1Department of Pediatrics, Division of Pediatric Nephrology, Chung Shan Medical and Dental College Hospital, Taichung, Taiwan, Republic of China. jimsheu@csh.org.tw
Insights
Intrauterine growth retardation (IUGR) is linked to more frequent relapses and steroid dependence in childhood minimal change nephrotic syndrome (MCNS). Early identification of IUGR can help predict a worse MCNS clinical course.
Area of Science:
- Pediatric Nephrology
- Neonatology
- Clinical Medicine
Background:
- Intrauterine growth retardation (IUGR) is associated with increased perinatal and adult morbidity/mortality.
- Minimal change nephrotic syndrome (MCNS) is a common cause of nephrotic syndrome in children.
- The impact of IUGR on the clinical course of pediatric MCNS is not well-defined.
Purpose of the Study:
- To investigate whether intrauterine growth retardation (IUGR) influences the clinical course of minimal change nephrotic syndrome (MCNS) in children.
- To identify potential risk factors for a more severe MCNS presentation.
Main Methods:
- Retrospective study of 50 children (aged 1-13 years) with MCNS.
- Diagnosis confirmed by renal biopsy in 50% of cases.
- Comparison of clinical outcomes between children with and without IUGR (birth weight <10th percentile).
Main Results:
- Children with IUGR (16% of cohort) experienced significantly more relapses (13.0 vs 3.4) and higher relapse rates (1.6 vs 0.5 per year).
- 100% of IUGR children developed steroid dependence compared to 21.4% without IUGR.
- IUGR children had increased use of cytotoxic agents/cyclosporine and a higher incidence of complications.
Conclusions:
- MCNS in children with IUGR follows a more unfavorable course with increased relapses and steroid dependence.
- IUGR may serve as an early indicator for identifying children at higher risk for severe MCNS.
- Consideration of more aggressive therapeutic strategies for MCNS patients with a history of IUGR is warranted.
Abstract:
It has been well established that intrauterine growth retardation (IUGR) is associated with greater morbidity and mortality rates during perinatal and adult life. The aim of this study is to clarify whether IUGR, defined as a birth weight less than the 10th percentile for gestational age, influences the clinical course of minimal change nephrotic syndrome (MCNS) in children. The study included 50 children aged 1 to 13 years at the onset of MCNS. The diagnosis of MCNS was confirmed by renal biopsy in 25 children (50%). Eight children (16%) had IUGR at birth. Comparisons between children with and without IUGR showed significant differences in mean number of relapses (13.0 +/- 3.5 versus 3.4 +/- 3.0 relapses; P < 0.0001) and relapse rates (relapses per year, 1.6 +/- 0.3 versus 0.5 +/- 0.4; P < 0.0001). We also observed a greater incidence of steroid dependence (100% versus 21.4%; P < 0.001) in children with than without IUGR. In addition, children with IUGR underwent treatment with cytotoxic agents and cyclosporine more frequently than those without IUGR. There was a significantly greater incidence of complications and concomitant diseases of nephrotic syndrome in children with IUGR; results show that MCNS in children with IUGR had a more unfavorable course and outcome. It is important for clinicians to be aware that IUGR may help in the early identification of children at greater risk for frequent relapses and the development of steroid dependence and/or steroid resistance. More aggressive therapy may be indicated for these children.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Nephrotic Syndrome I : Introduction
Nephrotic Syndrome II : Assessment and Medical Management
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury V: Interprofessional Care

